(Q43741282)

26 November 2017

Associations between homocysteine and coagulation factors--a cross-sectional study in two populations of central Europe (English)

1 reference

26 November 2017

1 reference

6

1 reference

26 November 2017

Kuch B

1

1 reference

26 November 2017

Bobak M

2

1 reference

26 November 2017

Fobker M

3

1 reference

26 November 2017

Junker R

4

1 reference

26 November 2017

von Eckardstein A

5

1 reference

26 November 2017

Hense HW

7

1 reference

26 November 2017

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

103

1 reference

26 November 2017

4

1 reference

26 November 2017

265-273

1 reference

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Putative mechanisms for vascular damage by homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

The role of fibrinogen as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Fibrin formation and degradation in patients with arteriosclerotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Homocysteine, vitamins, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900321-8

7 January 2021

10.1016/S0049-3848(01)00321-8

Identifiers

DOI

1 reference

26 November 2017

1 reference